Mounjaro Subcutaneous Injection
Mounjaro Subcutaneous Injection is a prescription dual GIP and GLP-1 receptor agonist containing tirzepatide that is used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is administered by subcutaneous injection using a sterile prefilled injection pen. The long-acting formulation provides convenient once-weekly dosing with accurate and reliable medication delivery.
Technical Specification
| Specification | Details |
|---|---|
| Product Name | Mounjaro Subcutaneous Injection |
| Active Ingredient | Tirzepatide |
| Dosage Form | Sterile Prefilled Injection Pen |
| Route of Administration | Subcutaneous Injection |
| Dosing Frequency | Once Weekly (As Prescribed) |
| Storage | Refrigerate at 2°C–8°C before first use |
Product Also Known As






